Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

<scp>NMRK2</scp> is an efficient diagnostic indicator for Xp11.2 translocation renal cell carcinoma

2 Aug 2024

Abstract excerpt

Abstract Xp11.2 translocation renal cell carcinomas (tRCC) are a rare and highly malignant type of renal cancer, lacking efficient diagnostic indicators and therapeutic targets. Through the analysis of public databases and our cohort, we identified NMRK2 as a potential diagnostic marker for distinguishing Xp11.2 tRCC from kidney renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma (KIRP)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endoplasmic Reticulum Stress and Disease
Share to Ferroptosis and cancer prognosis
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39092712
DOI: 10.1002/path.6340

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

<scp>NMRK2</scp> is an efficient diagnostic indicator for Xp11.2 translocation renal cell carcinomaPMID 39092712Read ↗

Mitochondrial Fusion RNA Signature and its Impact on KIRP Prognosis and Cisplatin SensitivitySemantic proximity Read ↗

The Role of MIEF2 in Cisplatin Sensitivity in KIRP Patients: Insights from Four-gene Mitochondrial Fusion RNA MarkersSemantic proximity Read ↗

Genomic alterations and diagnosis of renal cancerSemantic proximity Read ↗

Molecular approach of renal cell carcinoma using FISH method : a prospective study (23 cases) and state of the artSemantic proximity Read ↗

MicroRNA expression profiling of Xp11 renal cell carcinoma.Semantic proximity Read ↗

Comprehensive Analysis of 15 Cases of ELOC-RCC and Identification of Novel Mutation SiteSemantic proximity Read ↗

Xp11 Translocation Renal Cell Carcinoma (RCC): Extended Immunohistochemical Profile Emphasizing Novel RCC MarkersSemantic proximity Read ↗

Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.Semantic proximity Read ↗

MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular InsightsSemantic proximity Read ↗

Management of translocation carcinomas of the kidneySemantic proximity Read ↗

Integrative Clinical and Molecular Characterization of Translocation Renal Cell CarcinomaSemantic proximity Read ↗

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.